SCHEMBL2190989

SCHEMBL2190989

CCOC(=O)Cc1cc(N)ccc1OC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 0.49
KDM4E B2RXH2 3/20 0.47
GAA P10253 2/20 0.47
MAPT P10636 2/20 0.47
MAPK1 P28482 2/20 0.47
ALDH1A1 P00352 5/20 0.46
HSD17B10 Q99714 1/20 0.45
MAOB P27338 1/20 0.45
HTT P42858 2/20 0.44
TSHR P16473 1/20 0.44
HSD17B2 P37059 1/20 0.43
FDPS P14324 1/20 0.43
LMNA P02545 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
MAOA P21397 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
PKM P14618 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9159002 0.86 HSD17B10 (0.49) KDM4EGAAMAPTMAPK1ALDH1A1
SCHEMBL6350941 0.85 CYP4F2 (0.49) DPP4KDM4EGAAMAPTMAPK1
SCHEMBL15731823 0.85 MAPK1 (0.63) DPP4KDM4EGAAMAPTMAPK1
SCHEMBL23616869 0.84 MAPK8 (0.48) DPP4KDM4EALDH1A1HSD17B10LMNA
Hydrochloric Acid SCHEMBL6976943 0.84 CYP4F2 (0.48) DPP4KDM4EGAAMAPTMAPK1
SCHEMBL9081693 0.84 LMNA (0.47) DPP4KDM4EMAPTMAPK1ALDH1A1
SCHEMBL16364575 0.84 ALDH1A1 (0.51) ALDH1A1TSHRFDPSLMNACYP1A2
SCHEMBL3800298 0.83 HSD17B10 (0.67) DPP4KDM4EALDH1A1HSD17B10MEN1
SCHEMBL30104116 0.83 HSD17B10 (0.67) DPP4KDM4EALDH1A1HSD17B10MEN1
SCHEMBL6343901 0.83 DPP4 (0.47) DPP4KDM4EGAAMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1486491-B1 CARBOXYLIC ACID COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO (JP) 2011-07-13 EP disclosed
US-7351705-B2 Carboxylic acid compounds and a pharmaceutical agent comprising the compound as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-04-01 US disclosed
US-20050222216-A1 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed
EP-1486491-A1 CARBOXYOIC ACID COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2004-12-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222216-A1 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient UACA, CPA3, HCAR1 DPP4 1110/4885KDM4E 2796/4885GAA 2395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.